Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > NanCogenics Reports Research Findings on Tumor-Localization of Cancer Therapeutics

Abstract:
In a series of journal publications and technical presentations, culminating with the recent BioNanoMed 2013 Conference in Krems, Austria, this April, the Co-Founders of NanCogenics have presented a novel methodology for the tumor-directed targeting of chemotherapeutics for systemic administration. The Company is now advancing the technology platform on an initial clinical path as a treatment modality for breast cancers.

NanCogenics Reports Research Findings on Tumor-Localization of Cancer Therapeutics

Houston, TX | Posted on June 6th, 2013

The tumor-targeting technology platform is based on the use of external magnetic field gradients, generated by small permanent magnets that cause the therapeutic, tied to magnetic nanoparticles, to collect at a tumor site, whether primary or metastatic. Subsequently, the external magnetic gradient enables and enhances the movement of the therapeutic-nanoparticle complex into the tumor environment where the drug is "activated", resulting in a significant anti-tumor response. As a potential clinical procedure, the treatment modality is anticipated to provide cancer therapeutics having significantly higher therapeutic efficacy and effectiveness, with minimal side effects.

The Company's announcement comes amidst news from other research groups in Asia and Europe, that magnetic nanovectors offer significant promise for targeted or localized drug therapy. As noted by NanCogenics Co-Founder Dr. Jim Klostergaard, Professor at The University of Texas MD Anderson Cancer Center, "There is an emerging realization that despite much effort, the prevailing approach to development of targeted therapeutics has yielded too few clinical successes, and that the plasticity of tumors and the range of their mutations may undermine the basis for targeting individual signaling pathways." Dr. Klostergaard further points out that the NanCogenics approach adds a biophysical targeting component for localized delivery, intended to advance drug targeting technology significantly beyond conventional targeting methodologies.

The Company's use of arrays of small permanent magnets that shape and focus the magnetic field gradients, with the capacity to target both superficial and deeper-seated visceral tumors, whether primary or metastatic, offers the potential for individual "design" for a personalized treatment approach. The compactness and modular design of the Magnetic Localization Unit also presents a mobility feature, offering a capability to reach under-served populations, in addition to centers within established healthcare facilities.

The Co-Founders and Management Team of NanCogenics see the Company as a resource for the enhanced performance of therapeutics in general, and specifically for cancer therapeutics, delivering more drugs to the target site and less to normal tissue. The capacity to localize therapeutic agents in high concentrations at the tumor site, without the harmful side effects, will lead to more effective treatment regimens, greater patient compliance to therapy and improved outcomes, such as patient quality of life, longevity and survival rates.

####

About NanCogenics, Inc.
Safe Harbor Statement: Certain statement included in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of products and services, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. The company's expectations regarding future revenues are dependent upon the ability to develop and supply products and services that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions are generally considered forward-looking statements. These statements reflect current expectations.

For more information, please click here

Contacts:
Charles Seeney
Phone: 855.842.6771

Copyright © NanCogenics, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

NMTI announces breakthrough solutions for HAMR nanoantenna for next-generation ultra-high density magnetic storage November 21st, 2014

Leica Microsystems Presents Universal Hybrid Detector for Single Molecule Detection and Imaging at SfN and ASCB: Leica HyD SMD - the Optimal Detector for Precise and Reliable SMD data November 20th, 2014

Silver Nanoparticles Produced in Iran from Forest Plants Extract November 20th, 2014

Nano Sorbents Able to Remove Pollutions Caused by Oil Derivatives November 20th, 2014

Nanomedicine

Quantum mechanical calculations reveal the hidden states of enzyme active sites November 20th, 2014

Silver Nanoparticles Produced in Iran from Forest Plants Extract November 20th, 2014

Tokyo Institute of Technology research: Protein-engineered cages aid studies of cell functions November 19th, 2014

A novel method for identifying the body’s ‘noisiest’ networks November 19th, 2014

Discoveries

NMTI announces breakthrough solutions for HAMR nanoantenna for next-generation ultra-high density magnetic storage November 21st, 2014

UO-industry collaboration points to improved nanomaterials: University of Oregon microscope puts spotlight on the surface structure of quantum dots for designing new solar devices November 20th, 2014

Silver Nanoparticles Produced in Iran from Forest Plants Extract November 20th, 2014

Nano Sorbents Able to Remove Pollutions Caused by Oil Derivatives November 20th, 2014

Announcements

NMTI announces breakthrough solutions for HAMR nanoantenna for next-generation ultra-high density magnetic storage November 21st, 2014

Leica Microsystems Presents Universal Hybrid Detector for Single Molecule Detection and Imaging at SfN and ASCB: Leica HyD SMD - the Optimal Detector for Precise and Reliable SMD data November 20th, 2014

Silver Nanoparticles Produced in Iran from Forest Plants Extract November 20th, 2014

Nano Sorbents Able to Remove Pollutions Caused by Oil Derivatives November 20th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More












ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE